Skip to main content
. 2014 Apr;21(2):e229–e240. doi: 10.3747/co.21.1575

FIGURE 2.

FIGURE 2

Delay of filgrastim (fil) or pegfilgrastim (peg) administration after the first chemotherapy cycle. The graph represents only patients diagnosed with the most common cancers, and all data are based on documentation of primary or secondary prophylaxis in the patient charts. For the complete data set, including delays in the administration of granulocyte colony–stimulating factor when added to the most prevalent chemotherapy regimens, please see Tables v and vi.